Praziquantel has remained the drug of choice for schistosomiasis chemotherapy for almost
40 years. The pressing need to develop a new antischistosomal drug may necessitate …

The repeated chemotherapy of schistosomiasis has resulted in the emergence of drug-
resistant schistosome strains. The development of such resistance has drawn the attention …

Schistosomiasis continues to affect the health and quality of life of millions of people around
the world. Schistosomiasis has been ranked the second disease after malaria in terms of …

A detailed temporal examination was made of alterations induced by artemether in the
tegument of adult Schistosoma mansoni worms using scanning electron microscopy (SEM) …

Although the current treatment of schistosomiasis relies largely on praziquantel (PZQ), it has
not been successful in significantly reducing the overall rate of disease cases, one of the …

In this investigation, the effects of Sidr honey, Nigella sativa oil (black-seed oil) and Sidr
honey and black-seed oil together on the ultrastructure of tegument, gastrodermis and testes …

Currently, praziquantel is the only drug of choice for treatment of schistosomiasis. Reports of
praziquantel resistance raise concerns about future control of the disease. Therefore, the …

Some have claimed that triclabendazole, a safe and efficacious drug for the treatment of
fascioliasis, also exhibits antischistosomal properties, but results are conflicting. We …

Schistosomiasis is one of the neglected diseases causing considerable morbidity and
mortality throughout the world. Microtubules with its main component, tubulin play a vital role …

Objective To test the effect of benzimidazole-derived compound (compound BTP-Iso) on
cultured adult Schistosoma mansoni and clean Biomphalaria alexandrina snails. Methods …